Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD): Price and Financial Metrics

Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD)

Today's Latest Price: $56.17 USD

0.58 (1.04%)

Updated Oct 22 7:00pm

Add BUD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 29 in Beverages

See all "A" rated Strong Buy stocks

BUD Stock Summary

  • BUD has a higher market value than 98.08% of US stocks; more precisely, its current market capitalization is $94,127,331,452.
  • Of note is the ratio of Anheuser-Busch InBev SA's sales and general administrative expense to its total operating expenses; 98.51% of US stocks have a lower such ratio.
  • With a year-over-year growth in debt of 108.31%, Anheuser-Busch InBev SA's debt growth rate surpasses 87.88% of about US stocks.
  • Stocks that are quantitatively similar to BUD, based on their financial statements, market capitalization, and price volatility, are MDLZ, CVS, SNE, HDB, and ANTM.
  • Visit BUD's SEC page to see the company's official filings. To visit the company's web site, go to

BUD Stock Price Chart Interactive Chart >

Price chart for BUD

BUD Price/Volume Stats

Current price $56.17 52-week high $92.05
Prev. close $55.59 52-week low $32.58
Day low $55.00 Volume 1,533,148
Day high $56.27 Avg. volume 2,424,115
50-day MA $56.59 Dividend yield 1.51%
200-day MA $55.15 Market Cap 113.26B

Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD) Company Bio

Anheuser Busch InBev is the global leader in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. The company was founded in 1366 and is based in Leuven, Belgium.

BUD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$56.17$47.38 -17%

We started the process of determining a valid price forecast for Anheuser-Busch InBev SA with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Anheuser-Busch InBev SA ranked in the 42th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Anheuser-Busch InBev SA, consider:

  • The company's balance sheet shows it gets 48% of its capital from equity, and 52% of its capital from debt. Notably, its equity weight is greater than just 16.44% of US equities in the Consumer Defensive sector yielding a positive free cash flow.
  • The company's compound free cash flow growth rate over the past 5.01 years comes in at -0.03%; that's greater than just 20.93% of US stocks we're applying DCF forecasting to.
  • Anheuser-Busch InBev SA's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 2.09% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Anheuser-Busch InBev SA? See FIZZ, KMB, NWL, POST, and PSMT.

BUD Latest News Stream

Event/Time News Detail
Loading, please wait...

BUD Latest Social Stream

Loading social stream, please wait...

View Full BUD Social Stream

Latest BUD News From Around the Web

Below are the latest news stories about Anheuser-Busch InBev SA that investors may wish to consider to help them evaluate BUD as an investment opportunity.

Heineken Is Leveraged To Growth Markets And Has Above-Average Margin Leverage Potential

In a beverage market that doesn’t offer a lot of obvious bargains, I like to look for company-specific drivers and stories that could help separate a company from the pack, and I think Heineken (OTCQX:HEINY) has that. Heineken was an early mover in shifting its mix up-market (premiumization), which is...

Stephen Simpson, CFA on Seeking Alpha | October 2, 2020

Health and Wellness Food and Beverages Market to Grow Significantly by 2020-2027 with Profiling Players Anheuser-Busch InBev, Bright Food Co. Limited, Caldwell, Dohler

Health and wellness products are primarily food & beverages that are specially formulated to offer health and functional benefits to consumers. The categories in health & wellness food and beverage products are different from those in conventional food & beverage

OpenPR | September 30, 2020

Constellation Brands Continuing To Leverage Its High-Value Portfolio Through The Pandemic

In some ways, I think Constellation Brands (STZ) is the opposite of Molson Coors (TAP), a stock I wrote about recently. While Molson Coors has largely kept playing the hand it has, hoping to somehow generate better results by repositioning brands in fading categories, Constellation has used aggressive portfolio transformation...

Stephen Simpson, CFA on Seeking Alpha | September 24, 2020

Anheuser-Busch will stock fridge for year if decor of 'House of Budweiser' stays

A U.S. Navy Veteran covered the house with thousands of cans of beer be drank before his passing.

WCPO 9 | September 21, 2020

Grand jury indicts two Jefferson County Chiropractors and eight others for fraud scheme

ST. LOUIS, MO – Dr. Thomas Hobbs and Dr. Vivian Carbone-Hobbs of Jefferson County were indicted with two members of their office staff, a former union representative of Anheuser-Busch In Bev, and five patients with conspiring to fraudulently obtain disability benefits from the Social Security Administration and disability insurance payments from providers of long-term and short-term disability insurance. The indictment charges Dr. Hobbs, Dr. Carbone-Hobbs, Clarissa Pogue, Christina Barrera, James Ralston, Elizabeth Guetersloh, Glenda Johnson, Sheila Huffman, Shannon Nenninger, and Gary Walesky with various violations including: conspiracy to defraud; health care fraud; and, theft of government funds.

US Department of Justice | September 18, 2020

Read More 'BUD' Stories Here

BUD Price Returns

1-mo 6.93%
3-mo 3.01%
6-mo 35.00%
1-year -37.72%
3-year -51.65%
5-year -46.68%
YTD -31.04%
2019 26.90%
2018 -39.37%
2017 8.82%
2016 -13.33%
2015 14.62%

BUD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BUD Dividend History

Continue Researching BUD

Here are a few links from around the web to help you further your research on Anheuser-Busch InBev SA's stock as an investment opportunity:

Anheuser-Busch InBev SA (BUD) Stock Price | Nasdaq
Anheuser-Busch InBev SA (BUD) Stock Quote, History and News - Yahoo Finance
Anheuser-Busch InBev SA (BUD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7107 seconds.